Phase 2 Readout~quarter
Phase 2 Readout: nimacimab
- Company
- Skye Bioscience, Inc. (SKYE)
- Drug
- nimacimab
- Indication
- obesity
Other upcoming events for SKYE
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.